Vaxart Announces Update to BARDA Funding Award to Reflect Current Scope of COVID-19 Oral Pill Vaccine Trial
Go back to Vaxart Announces Update to BARDA Funding Award to Reflect Current Scope of COVID-19 Oral Pill Vaccine Trial| (NASDAQ: VXRT) | Delayed: 0.32 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.32 | 52 Week High | $ | |||
| Open | $0.32 | 52 Week Low | $ | |||
| Day High | $0.32 | P/E | N/A | |||
| Day Low | $0.32 | EPS | $ | |||
| Volume | 503,141 | |||||
